Find a company by name or ticker and open its page
We use analytics cookies to understand how you use Stockoscope and improve the platform. Essential cookies that keep you logged in are always on. Cookie policy
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
IDXXZacks Investment ResearchGet a deeper insight into the potential performance of Idexx (IDXX) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Also in the news
IDXXZacks Investment ResearchIDXX heads into Q3 earnings with expected revenue and EPS growth, fueled by CAG Diagnostics momentum, higher testing volumes and software gains.
IDXXZacks Investment ResearchFinding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
IDXXZacks Investment ResearchIdexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IDXXZacks Investment ResearchIdexx (IDXX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
IDXXDefense WorldAssenagon Asset Management S.A. raised its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 39.9% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 256,362 shares of the company's stock after buying an additional 73,129 shares during the quarter. Assenagon Asset Management S.A. owned about 0.33%